Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.
Marchi N, Fazio V, Cucullo L, Kight K, Masaryk T, Barnett G, Vogelbaum M, Kinter M, Rasmussen P, Mayberg MR, Janigro D.
Marchi N, et al.
J Neurosci. 2003 Mar 1;23(5):1949-55. doi: 10.1523/JNEUROSCI.23-05-01949.2003.
J Neurosci. 2003.
PMID: 12629200
Free PMC article.
Clinical Trial.